Athersys hires pharma, biotech leader as next CEO
Athersys Inc., the adult stem cell company in Cleveland, has hired a senior pharmaceutical and biotech executive as its next CEO to complete the company's efforts to commercialize its MultiStem therapy. Daniel Camardo is executive vice president, head of the rare disease and inflammation business units, and U.S. president at Horizon Therapeutics, the Irish biotech company. Camardo also will join the Athersys board.